Blood News and Research RSS Feed - Blood News and Research

Women who take stop-smoking drug Zyban during pregnancy give birth to a child with birth defects

Women who take stop-smoking drug Zyban during pregnancy give birth to a child with birth defects

The Arentz Law Group is currently investigating cases of birth defects caused by the stop-smoking drug Zyban. Women who have taken Zyban while pregnant, and given birth to a child born with a birth defect, are encouraged to contact the law firm immediately for a free legal consultation. [More]
Cognizin citicoline shows promise in patients with bipolar disorder and cocaine dependence

Cognizin citicoline shows promise in patients with bipolar disorder and cocaine dependence

The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks. [More]
Southern Research receives $22 million to support HIV cure initiative

Southern Research receives $22 million to support HIV cure initiative

Southern Research has been awarded a seven-year contract of up to $22 million to support research that could contribute to the cure of HIV disease. Under this contract, Southern Research will develop and standardize assays that quantitate latent reservoirs of HIV. [More]
Omega-3 fish oil supplements can improve cardiovascular health of healthy seniors

Omega-3 fish oil supplements can improve cardiovascular health of healthy seniors

Bethesda, Md. (July 6, 2015)—Fish oil is one of the most popular dietary supplements in the U.S. because of the perceived cardiovascular benefits of the omega-3 it contains. [More]
Patients who receive intracranial stents at increased risk of experiencing another stroke

Patients who receive intracranial stents at increased risk of experiencing another stroke

The risk of experiencing another stroke is higher if patients, after dilation of their blood vessels in the brain, receive not only clot-inhibiting drugs, but also have stents inserted. The recently published results of the VISSIT study confirm this conclusion of a rapid report by the German Institute for Quality and Efficiency in Health Care (IQWiG) of October 2014. [More]
Mild head injury patients having lower serum S100B levels unlikely to have intracranial hemorrhage

Mild head injury patients having lower serum S100B levels unlikely to have intracranial hemorrhage

Researchers conducted a prospective observational study in elderly patients and adult patients receiving antiplatelet therapy who presented with mild head injury at two trauma hospitals in Vienna: the Trauma Hospital Meidling and the Donauspital. [More]
Discovery could pave way to new treatments for malaria

Discovery could pave way to new treatments for malaria

Scientists have discovered new ways in which the malaria parasite survives in the blood stream of its victims, a discovery that could pave the way to new treatments for the disease. [More]
New research shows that risk of cardiovascular disease and early death falls due to vitamin C

New research shows that risk of cardiovascular disease and early death falls due to vitamin C

New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that high vitamin C concentrations in the blood from the intake of fruit and vegetables are associated with a reduced risk of cardiovascular disease and early death. [More]
City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

City of Hope researchers to use patients' own modified T cells to treat advanced brain tumors

Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine's biggest challenges: brain cancer. This month, they will launch a clinical trial using patients' own modified T cells to fight advanced brain tumors. [More]
Physical and psychological factors related to cognitive function vary in older women with ischemic stroke

Physical and psychological factors related to cognitive function vary in older women with ischemic stroke

An estimated 65 percent of ischemic stroke survivors experience cognitive impairment and decline. However, little is known about the varying roles of cognitive risk and protective factors before, during and after stroke. [More]
Henry Ford Hospital wins Get With The Guidelines-Stroke Gold Quality Achievement Award

Henry Ford Hospital wins Get With The Guidelines-Stroke Gold Quality Achievement Award

The Stroke and Neurovascular Disease Center at Henry Ford Hospital in Detroit has received the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke Gold Quality Achievement Award. [More]
Researchers pinpoint two biomarkers elevated in severe form of coronary disease

Researchers pinpoint two biomarkers elevated in severe form of coronary disease

Insulin resistance affects tens of millions of Americans and is a big risk factor for heart disease. Yet, some people with the condition never develop heart disease, while some experience moderate coronary blockages. Others, though, get severe atherosclerosis - multiple blockages and deterioration of coronary arteries characterized by thick, hard, plaque-ridden arterial walls. [More]
Dental pulp stem cell transplants can contribute to peripheral nerve regeneration

Dental pulp stem cell transplants can contribute to peripheral nerve regeneration

Peripheral nerve injuries often are caused by trauma or surgical complications and can result in considerable disabilities. Regeneration of peripheral nerves can be accomplished effectively using autologous (self-donated) nerve grafts, but that procedure may sacrifice a functional nerve and cause loss of sensation in another part of the patient's body. [More]
Findings reveal new pathway to develop effective treatments and therapies for asthma, allergy

Findings reveal new pathway to develop effective treatments and therapies for asthma, allergy

Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that scientists could use to develop more effective treatments and therapies for the chronic lung disorder. [More]
New portable system can produce life-saving NO from air by means of electrical spark

New portable system can produce life-saving NO from air by means of electrical spark

Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price. [More]
Disproportionate number of older people hospitalized in Canada with TBI

Disproportionate number of older people hospitalized in Canada with TBI

A disproportionate number of people hospitalized in Canada with traumatic brain injuries are 65 years or older, a new study from St. Michael's Hospital has found. [More]
Study could provide paradigm shift in treatment of age-related disease, cancer

Study could provide paradigm shift in treatment of age-related disease, cancer

Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including many chemotherapies. [More]
Blood-borne molecule promotes age-related cognitive decline

Blood-borne molecule promotes age-related cognitive decline

A blood-borne molecule that increases in abundance as we age blocks regeneration of brain cells and promotes cognitive decline, suggests a new study by researchers at UC San Francisco and Stanford School of Medicine. [More]
Using nanocarriers and microbubbles in drug delivery for treating thrombotic disease

Using nanocarriers and microbubbles in drug delivery for treating thrombotic disease

Future Science Group today announced the publication of a new article in Future Science OA, covering the use of nanocarriers and microbubbles in drug delivery for thrombotic disease. [More]
Transitioning infrared imaging into clinical use: an interview with Dr Matthew Baker

Transitioning infrared imaging into clinical use: an interview with Dr Matthew Baker

The CLIRSPEC network is a UK Engineering and Physical Sciences Research Council (EPSRC – EP/L012952/1) funded network in clinical infrared and Raman spectroscopy. Infrared and Raman spectroscopy can identify the hallmarks of disease and distinguish between diseased and non-diseased samples based upon inherent chemistry. [More]
Advertisement
Advertisement